Norcliffe Capital Limited

Dxcover — a Glasgow-based company developing a blood test that can detect cancer at an early stage — has raised £9.7 million through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset M

Glasgow-based ClinSpec Diagnostics Limited (ClinSpec Dx) has reached its round two funding target of £3.5 million by securing an additional investment of £1.1m. The firm which develops liquid biopsies for early detection of cancer has secured the £1.1m investment from Norcliffe Cap